Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
6(19%)
Results Posted
8%(1 trials)
Terminated
2(6%)

Phase Distribution

Ph not_applicable
8
25%
Ph phase_4
1
3%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

13 of 16 finished

Non-Completion Rate

18.8%

3 ended early

Currently Active

6

trials recruiting

Total Trials

32

all time

Status Distribution
Active(8)
Completed(13)
Terminated(3)
Other(8)

Detailed Status

Completed13
unknown8
Recruiting4
Active, not recruiting2
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
6
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (11.1%)
N/A8 (88.9%)

Trials by Status

active_not_recruiting26%
terminated26%
completed1341%
withdrawn13%
recruiting413%
enrolling_by_invitation13%
unknown825%
not_yet_recruiting13%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT03924661

SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy

Active Not Recruiting
NCT05404100

Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis

Completed
NCT05847751

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis

Active Not Recruiting
NCT04204915Not Applicable

The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

Recruiting
NCT06964035

Influence of Original Native Aortic Valve Lesion (Stenosis or Steno-insufficiency vs. Insufficiency) on Post-implant Structural Bioprosthetic Degeneration After Aortic Valve Replacement

Enrolling By Invitation
NCT04430972

Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)

Not Yet Recruiting
NCT02278666

Minimally Invasive Versus Conventional Aortic Valve Replacement: a Long Term Registry

Completed
NCT05912660

Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

Completed
NCT05774808

Fate of Moderate Secondary Mitral Regurgitation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Regurgitation

Completed
NCT03667365Not Applicable

Randomized Study for the Optimal Treatment of Symptomatic Patients With Low Gradient Severe Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction

Terminated
NCT05627973

Health Status of < 50 Year Old Patients After Surgically Implanted Biological and Mechanical Aortic Valves: a Population-based Retrospective Analysis (2010-2020)

Completed
NCT04900909

Health Status of Patients After Surgically Implanted Biological and Mechanical Aortic Valves: a Population-based Retrospective Analysis (2010-2018)

Completed
NCT05235529

Neuropsychological and Neuroimaging Evaluation of the Cognitive Impairment in Aortic Valve Replacement (ARTiCO)

Unknown
NCT04223713Not Applicable

4D- Flow- MRI After Aortic Valve Surgery

Unknown
NCT03972644Not Applicable

Danish National Randomized Study on Early Aortic Valve Replacement in Patients With Asymptomatic Severe Aortic Stenosis

Recruiting
NCT04455165

Factors Influencing Morbi-mortality in Right Anterior Minithoracotomy Approch for Aortic Valve Replacement

Completed
NCT03143361

Prospective European Multicenter Study on Aortic Valve Replacement: (E-AVR Registry)

Recruiting
NCT03385915

Finnish Registry of Transcatheter and Surgical Aortic Valve Replacement for Aortic Valve Stenosis: FinnValve Registry

Completed
NCT04277572

Outcomes of Surgery of Aortic Valve

Unknown
NCT03976817

Aortic Valve Replacement Above the Aortic Annulus (SA-AVR) With the Carpentier-Edwards Magna-Ease Bioprosthesis

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
32